Characterization of Methicillin
resistant Staphylococcus aureus strains from clinical isolates in a
tertiary care hospital of south India
Geeta SH1, Kalghatgi AT2,
Rama NK3
Department of Microbiology, MVJ Medical College & Research
Hospital, Hoskote, Bangalore, India
Address for
correspondence: Dr Geeta S H, Email:
drgeetashashikant@gmail.com
Abstract
Methicillin resistant staphylococcus aureus (MRSA) strains which are
the most frequent cause of hospital acquired infections (HAI), are also
currently encountered with increasing frequency in the community.
Phenotypic detection of methicillin resistance is inadequate, due to
environmental factors & heterogeneous resistant strains which
may affect the phenotypic expression of resistance. Phenotypic methods
for MRSA detection have been compared with the gold standard which is
Polymerase Chain Reaction (PCR) for mecA gene. Discrepancies in
detection have an adverse effect on patient management, thereby
highlighting the importance of accuracy in diagnosis. Therefore rapid
& accurate identification is essential for both implementation
of infection control measures & prevention of nosocomial spread
of the organism. Materials
& Methods: 166 S. aureus isolates were studied out
of a total of 677 staphylococcal samples. Methicillin resistance were
detected using oxacillin disc diffusion (ODD), cefoxitin disc diffusion
(CxDD), oxacillin screen agar (OSA) & PCR for mecA gene, using
standard protocol. Results:
Out of 166 S. aureus isolated, MRSA prevalence was seen in 26.5%. MRSA
was identified in 44 (100%) by CxDD, 43 (98%) by OSA and 38 (86.4%) by
ODD methods respectively. When these isolates were tested with
molecular methods, the CxDD and PCR test results were comparable.
However by antibiotic susceptibility test (AST), no strain was
resistant to vancomycin, linezolid & teicoplanin. Conclusion: To
reduce the prevalence of MRSA, regular surveillance of HAI &
monitoring of AST is the need of the hour. Proper detection of all MRSA
isolates with rapid & accurate methods must be done as a
routine laboratory procedure.
Keywords: S.
aureus, MRSA, phenotypic tests, AST, mecA gene
Manuscript Received: 24th
Sept 2015, Reviewed:
7th Oct 2015
Author Corrected:
17th Oct 2015, Accepted
for Publication: 27th Oct 2015
Introduction
Staphylococcus aureus (S. aureus) is a bacteria of
significant importance because of its ability to cause a wide range of
diseases and its capacity to adapt to diverse environmental forms. S.
aureus is a gram positive organism that serves as an opportunistic
pathogen & frequent colonizer of epithelium causing severe
diseases in man & animals [1, 2].
The incidence of Methicillin Resistant Staphylococcus aureus (MRSA) in
India ranges from 30 – 70%. MRSA strains harbour mecA gene
which encodes a modified (Penicillin binding protein) PBP2a with low
affinity for methicillin and all -lactam antibiotics. Since MRSA are
resistant to all -lactam antibiotics, the therapeutic options are
limited significantly, and therefore their accurate identification
becomes important. Phenotypic expression of methicillin resistance may
alter depending on the growth conditions of S. aureus which may affect
the accuracy of the methods used to detect methicillin resistance [3].
There are many methods available for the detection of MRSA. Cefoxitin
is a potent inducer of mecA gene regulatory system. In recent years
there are multiple published-reports which suggest the use of cefoxitin
as surrogate marker for the detection of mecA gene mediated S. aureus
resistance. Clinical Laboratory Standards Institute (CLSI) guidelines
recommend cefoxitin to be used to identify MRSA, using a 30g cefoxitin
disc and a zone of ≤19 mm is considered as resistance strain [4].
The introduction of methicillin in 1960s had an important impact on the
treatment of infections caused by penicillinase producing S. aureus.
Shortly later, MRSA strains with a PBP appeared and spread worldwide.
Such resistance mechanism is due to production of a modified PBP2a with
low affinity to β–lactam antibiotics as a result of
the acquisition of a mecA gene. It can be difficult to detect MRSA
because of the heterogeneous nature of methicillin resistance. The mecA
gene is highly conserved among the Staphylococcal species and
consequently, the detection of this gene by the PCR is considered as
the “gold standard” for the detection of
methicillin resistance in Staphylococci. The existence of the mecA gene
in S. aureus characterizes methicillin resistance [5].
Staphylococcal resistance was reported shortly after penicillin was
introduced, and within approximately 5-6 years, 25% of community
isolates were penicillin resistant. Although the rates are only
approximate because they are based on reports from numerous locations,
a clear correlation exists between the prevalence of penicillin
resistant strains of S. aureus reported in hospitals and rates in the
community. Strains of MRSA, which had been largely confined to
hospitals and long-term care facilities, are emerging in the community.
The changing epidemiology of MRSA bears striking similarity to the
emergence of penicillinase mediated resistance in S. aureus since
decades ago. Even though the origin (hospital or the community) of the
emerging MRSA strains is not known, the prevalence of these strains in
the community seems likely to increase substantially [6].
Resistance to penicillin is determined by the mecA gene, which encodes
the low affinity PBP2a. Lately, new methicillin resistance gene, mecC
has been discovered from humans, animals and food products. This new
mecA homolog has been detected in bacteria from dairy cattle in England
and humans in England, Scotland and Denmark. This newly identified
protein has a ≤ 63% similarity with the PBP2a encoded by mecA
[7].
Laboratory diagnosis and susceptibility testing are crucial steps in
the treatment, control and prevention of MRSA infections. Hence methods
used to detect MRSA in clinical samples should have high sensitivity
and specificity with the results available within a short time. Various
methods have evolved for rapid detection of MRSA but the optimal method
remains controversial. The most commonly used methods in laboratories
are culture and sensitivity test, oxacillin disc diffusion (ODD),
mannitol salt agar (MSA), oxacillin screen agar (OSA), broth and agar
dilution tests etc. All these are conventional phenotypic methods of
MRSA identification. Genotypic method is the polymerase chain reaction
(PCR) based method for detecting mecA gene which remains the gold
standard for MRSA [8].
The phenotypic methods in general are easier to perform and interpret,
cost effective and are widely available, however less discriminatory.
The genotypic methods are expensive and technically demanding, and more
precise. Newer technologies involving sequencing of various genes are
coming up as broadly applicable typing systems. Still there is no
consensus regarding the single best method for detection of MRSA
strains. Application of any identification method requires careful
assessment of its suitability and an individual approach depending on
the purpose of the study [9].
Aims
and Objectives
1. To study the prevalence of MRSA in a tertiary care
hospital.
2. To compare the various phenotypic methods for isolation of
MRSA.
3. Detection of mecA gene by genotyping for
confirmation of the isolated MRSA strains.
Materials
& Methods
The study was conducted in our teaching hospital from Jan –
Dec 2014. The study was commenced after getting the ethical clearance
from the Institutional Ethics Committee.
From a total of 677 staphylococci studied from various clinical
samples, 166 S. aureus strains were isolated, identified and
characterized as per recommended standard protocol [10, 11].
All the isolates were tested for methicillin resistance by disc
diffusion using oxacillin (1g), cefoxitin (30g), MSA & OSA
methods [Himedia India].
The isolates were subjected to AST by Kirby Bauer disc diffusion
method.
Antibiotics tested were penicillin (10 units), ampicillin (10g),
cephalexin (30g), oxacillin (1g), cefoxitin (30g), erythromycin
(15g), clindamycin (2g), ciprofloxacin (5g), ofloxacin (10g),
gentamycin (10g), amikacin (30g), linezolid (30g), vancomycin
(30g), cotrimoxazole (25mcg)& teicoplanin (30g). Zone
diameters were measured as per CLSI criteria [11].
Oxacillin screen agar: Mueller Hinton agar (MHA) with 4% NaCl and
oxacillin 6g/ml was prepared. The 0.5 McFarland suspension of the test
strains was inoculated as spots over the plates, incubated at 350C for
24 hours. The strains which were able to grow on this medium were
designated as MRSA.
Oxacillin and cefoxitin disc diffusion test: MHA plates were overlaid
with a saline suspension of the isolate (0.5 McFarland), cefoxitin
(30g) and oxacillin (1g) were placed on the plates. After 24-48 hours
of incubation at 350C, the plates were read using CLSI cut off points
as reistant (<19mm cefoxitin; <10mm oxacillin).
Molecular detection of mecA gene by PCR: S. aureus DNA extraction was
performed by using Gene Elute Genomic DNA kit (Sigma Aldrich). The
primers used for detection of mecA gene were [12]:
mecA1: 5’ – GTAGAAATGACTGAACGTCCGATAA
mecA2: 5’ – CCAATTCCACATTGTTTCGGTCTAA
The target gene was amplified using the above set of primers by PCR in
a 100l of reaction mixture containing dNTPs (200M), 2.5M (each
primers), 2.5U of Taq DNA polymerase (Bangalore Genei), 50mM KCl, 10mM
Tris-HCl, 1.5mM MgCl2 & 0.01% gelatin.
The procedure steps were as follows: Pre-denaturation for 4 minutes at
940C, denaturation for 45s at 940C: annealing for 45s at 550C, primer
extension for 1min at 720C. Each step was repeated 30 times. For
visualization, 10l of PCR amplicon was loaded in 2% agarose gel with
ethidium bromide. The band of amplified DNA was visualised under UV
trans-illuminator. A 310 bp amplicon corresponds to the mecA gene shown
in the fig [13].
Quality Control
1. S. aureus ATCC 25923 was used as standard control strain.
2. In-house strain of S. aureus showing sensitivity to
cefoxitin.
The viability of the isolates, was maintained by periodic subculture on
semi-solid nutrient agar.
Results
Out of the 677 Staphylococcal isolates from various clinical specimen,
S. aureus was present in 166 samples (24.5%). Out of 166 S. aureus,
MRSA was the isolate in 44 (26.5%).
Table 1 shows the
Sample-wise distribution of MRSA: Pus 29 (65.9%), Blood 13
(29.5%) and ET tip 02 (4.6%). The maximum isolation of MRSA was from
surgical departments (45.4%) – Surgery 14 (31.8%) &
Orthopaedics 06 (13.6%).
Table 2 shows the
phenotypic & genotypic characteristics of MRSA isolates:
MRSA detection by OSA & CxDD was 98% & 100% and by ODD
method it was 86.4%; mecA gene detection by molecular methods gave
comparable results with that of CxDD.
Table 3 shows the
antibiotic susceptibility pattern of the MRSA strains: The
isolates were highly resistant to cefoxitin (100%), ampicillin (95.5%),
cephalexin (95.5%), ciprofloxacin & gentamycin (75%) each
& erythromycin (68%); and were moderately resistant to
cotrimoxazole (48%) & clindamycin (52%). All the strains were
100% sensitive to linezolid, teicoplanin & vancomycin.
Figure I:
Shows the different tests used in characterization of Methicillin
resistant Staphylococcus aureus
Figure II: Shows
the Genotyping results of the MRSA Isolates in the study
Discussion
MRSA are being recognised as important human pathogens causing
significant morbidity & mortality in hospitals and community;
and are difficult to eradicate because they are multi-drug resistant.
With reference to world-wide resistance among S. aureus strains, early
detection of reduced susceptibility to -lactam antibiotics is
important for clinicians. CLSI recommends use of cefoxitin as preferred
method for testing S. aureus as surrogate marker for detecting
oxacillin resistance. Detection of mecA gene or its product PBP2a is
considered the gold standard for MRSA confirmation [11]. The prevalence
of MRSA in our hospital was found to be 26.5%. Similar isolation rates
were also found in studies byKumari N et al &Pramodhini Set al
[14, 15].Higher prevalence rates ranging from 40 – 60% were
found in some studies [16, 17]. This variation might be because of
changes in antibiotic usage & infection control practices in
different hospitals.
In the present study, maximum isolation of MRSA was from Surgery
& Paediatrics departments (31.8%) each, followed by Ortho
(13.6%), OBG (9%) & Medicine (4.5%) which correlates with pus,
blood & other samples. Similar results were reported by Kumari
N et al &Pramodhini S et al., which can be explained by the
fact that Staphylococcus will be present as part of the commensal flora
of the skin [14, 15].
CxDD was found to be highly sensitive & specific (100%) while
sensitivity & specificity of ODD was 94% & 80%. The
results of disc diffusion methods showed that CxDD is a better
alternative for MRSA detection. Similar results were quoted in several
other studies [3, 8, 18, 15, 21].
Sensitivity & specificity of OSA were 100% & 99%.
Similar finding were reported by Pramodhini S et al, Kumar S et al,
Murakami K et al & Manju Pillai et al [15, 18, 21, 8].
In the present study, isolated MRSA strains were 100% sensitive to
linezolid, vancomycin & teicoplanin. The isolates were highly
resistant to cefoxitin, ampicillin & cephalexin (95 –
100%). The isolates showed varying resistance to other antibiotics like
erythromycin (68.2%), clindamycin (52%) & cotrimoxazole (48%).
AST report in the present study was coherent with that in the study by
Anupurba et al [17].
Our study showed sensitivity & specificity of genotyping by PCR
for MRSA to be 100% which was in concordance with other studies like
James John et al, Kumar S et al, Manju Pillai et al, Swenson JM et al
& Fernandes CJ et al [4, 18, 8, 19, 20].
Conclusion
Rapid and accurate identification of MRSA is required for therapeutic
and epidemiological reasons; to immediately start appropriate
antimicrobial therapy & to avoid the spread of these strains.
Phenotypic methods are still preferred for species identification. But
for the reliable detection of MRSA an algorithm should include a
combination of tests; and apply a genotypic method for confirmation of
resistant isolates showing discordant results. The hospital infection
control policy & guidelines should be strictly implemented so
as to enable clinicians to deliver better and proper health care to the
patients. Results of cefoxitin disc diffusion test is in concordance
with the genotyping results for mecA gene. So this test can be an
alternative to PCR for detection of MRSA in resource constraint
settings.
Funding:
Nil, Conflict of
interest: None initiated.
Permission
from IRB:
Yes
References
1. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998 Aug
20;339(8):520-32. [PubMed]
2. Hafsat Ali Grema, Yaqub Ahmed Geidam, Galadima Bala Gadzama, James
Agbo Ameh, Abubakar Suleiman. Methicillin Resistant Staphylococcus
aureus: A Review. Adv Anim Vet Scien. 2015; Vol 3 (2): 79 –
98.DOI | http://dx.doi.org/10.14737/journal.aavs/2015/3.2.79.98. [PubMed]
3. Mathews AA, Thomas M, Appalaraju B, Jayalakshmi J. Evaluation and
comparison of tests to detect methicillin resistant S. aureus. Indian J
Pathol Microbiol. 2010 Jan-Mar;53(1):79-82. doi:
10.4103/0377-4929.59189. [PubMed]
4. Sangeetha G, James John, Ranjith J. Comparison of different
phenotypic methods with PCR detection of mecA gene for detection of
Methicillin Resistant Staphylococcus aureus. Int J Pharmacy and
Pharmaceutica Sci. 2012; Vol 4 (Suppl 4): 495-7. ISSN- 0975-1491.
5. Mounir M Salem Behkit. Phenotypic and Genotypic characterisation of
Staphylococcus aureus isolates with reference to Methicillin
resistance. Trop J Pharma Res. 2014; 13 (8): 1239-1246.DOI |
http://dx.doi.org/10.4314/tjpr.v13i8.7ISSN: 1596-5996 (print);
1596-9827 (electronic) [PubMed]
6. Chambers HF. The changing epidemiology of Staphylococcus aureus?
Emerg Infect Dis. 2001 Mar-Apr;7(2):178-82. [PubMed]
7. Porrero MC, Valverde A, Fernández-Llario P,
Díez-Guerrier A, Mateos A, Lavín S,
Cantón R, Fernández-Garayzabal JF,
Domínguez L. Staphylococcus aureus carrying mecC gene in
animals and urban wastewater, Spain.Emerg Infect Dis. 2014
May;20(5):899-901. doi: 10.3201/eid2005.130426.
8. Pillai MM, Latha R, Sarkar G. Detection of methicillin resistance in
Staphylococcus aureus by polymerase chain reaction and conventional
methods: a comparative study. J Lab Physicians. 2012 Jul;4(2):83-8.
doi: 10.4103/0974-2727.105587. [PubMed]
9. Mehndiratta PL, Bhalla P. Typing of Methicillin resistant
Staphylococcus aureus: a technical review. Indian J Med Microbiol. 2012
Jan-Mar;30(1):16-23. doi: 10.4103/0255-0857.93015. [PubMed]
10. Collee JG, Fraser AG, Duguid JP, Marmion BP, Simmons A. Mackie
& McCartney Practical Medical Microbiology. 1996. 14th Ed.
Churchill Livingstone, New York.
11. Clinical & Laboratory Standard Institute. Performance
standards for antimicrobial susceptibility testing; twenty third
informational supplement. CLSI document. Wayne, PA. 2013; CLSI: M100
– S23. [PubMed]
12. Geha DJ, Uhl JR, Gustaferro CA, Persing DH. Multiplex PCR for
identification of methicillin-resistant staphylococci in the clinical
laboratory. J Clin Microbiol. 1994 Jul;32(7):1768-72. [PubMed]
13. Protocol for PCR amplification of mecA, mecC, SPA & PVL
(recommended by EURL-AR). DTU National Food Institute, Sep 2012. 2nd
version, 1 – 5.
14. Kumari N, Mohapatra TM, Singh YI. Prevalence of
Methicillin-resistant Staphylococcus aureus (MRSA) in a Tertiary-Care
Hospital in Eastern Nepal. JNMA J Nepal Med Assoc. 2008
Apr-Jun;47(170):53-6. [PubMed]
15. Pramodhini S, Tenmozhivalli PR, Selvi R, Dillirani V, Vasumathi A,
Agatha D. Comparision of various phenotypic methods &mecA based
PCR for the detection of MRSA. J Clin Diagn Res. 2011;5(7):1359
– 62.
16. Muralidharan S. Special article on Methicillin Resistant S. aureus.
J Acad Clin Microbiol. 2009; 11: 15 – 16.
17. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM.
Prevalence of methicillin resistant Staphylococcus aureus in a tertiary
referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol.
2003 Jan-Mar;21(1):49-51.
18. Anand KB, Agrawal P, Kumar S, Kapila K. Comparison of cefoxitin
disc diffusion test, oxacillin screen agar, and PCR for mecA gene for
detection of MRSA. Indian J Med Microbiol. 2009 Jan-Mar;27(1):27-9. [PubMed]
19. Swenson JM, Tenover FC; Cefoxitin Disk Study Group. Results of disk
diffusion testing with cefoxitin correlate with presence of mecA in
Staphylococcus spp. J Clin Microbiol. 2005 Aug;43(8):3818-23. [PubMed]
20. Fernandes CJ, Fernandes LA, Collignon P; Australian Group on
Antimicrobial Resistance. Cefoxitin resistance as a surrogate marker
for the detection of methicillin-resistant Staphylococcus aureus. J
Antimicrob Chemother. 2005 Apr;55(4):506-10. Epub 2005 Mar 2.
21. Kazuhisa Murakami, Wakio Minamide, Koji Wada, Etuo Nakamura,
Hiroshi Teraoka and Sachihiko Watanabe. Identification of
Methicillin-Resistant Strains of Staphylococci by Polymerase Chain
Reaction. J Clin Microbiol. 1991; Vol. 29(10): 2240 – 44.
How to cite this article?
Geeta SH, Kalghatgi AT, Rama NK. Characterization of Methicillin
resistant Staphylococcus aureus strains from clinical isolates in a
tertiary care hospital of south India. Int J Med Res Rev
2015;3(9):1077-1083. doi: 10.17511/ijmrr.2015.i9.196.